Emergency Room Wait Times
Home > Clinical Trials > Clinical Trial Details
<< Back to Results
Request Additional Trial InformationFull Trial Details: ClinicalTrials.gov
Condition: Prostate Cancer Study Type: Interventional Phase: Phase II Study Start Date: 01/01/2015Study Completion Date: 12/31/2019
A Phase 1/2 multicenter, dose determining, open-label study of ADXS31-142 monotherapy and a combination of ADXS31-142 with Pembrolizumab (MK-3475) in patients with metastatic castration-resistant prostate cancer. Part A will be dose-determining of ADXS31-142 monotherapy. Part B will be dose-determining of ADXS31-142 and Pembrolizumad (MK-3475) in combination. Part B expansion will treat additional patients with the recommended dose from Part B.
Find an Adventist HealthCare affiliated doctor by calling our FREE physician referral service at 800-642-0101 or by searching our online physician directory.
Set Your Location
Setting your location helps us to show you nearby providers and locations based on your healthcare needs.